CONNECT WITH US
HealthTech

HealthTech

HonorHealth’s Whitfill Says His System Treats AI Investments Like a Venture Portfolio

HealthSystemCIO logo

Published on

Add as a preferred source on Google
HonorHealth’s Whitfill Says His System Treats AI Investments Like a Venture Portfolio

HonorHealth EVP Dr. Jim Whitfill explains how his system weighs returns on AI spending and why he favors guardrails on token costs. Watch below or on YouTube.

HonorHealth can require its most expensive AI resources to project a 4-to-1 financial return before work starts, and it holds other AI tools to lighter tests. Dr. Jim Whitfill, EVP, Strategy, Transformation and Digital at the nine-hospital Arizona system, laid out the approach on a recent episode of the healthsystemCIO Show. AI is moving so fast that it is hard to know exactly where its value will come from, he said, so HonorHealth spreads its AI investments across four lanes. Lanes that produce results get more money. Lanes that stall, meanwhile, are paused, rethought and restarted.

The approach borrows from the way venture capitalists build a portfolio, Whitfill said. In his rough illustration, a firm backing 10 companies expects one to hit big, two to do fine and seven to fail, so it spreads the risk. HonorHealth’s first lane, for example, gives operators Microsoft Copilot to find efficiencies in their daily work. The second draws on AI that Epic and Workday, its EHR and ERP vendors, build into their products. In the third, HonorHealth builds its own AI on Google’s cloud, where its analytics and data already sit.

The fourth lane is a partnership with Qventus that embeds five AI engineers at HonorHealth. They take on complex work with potentially high returns, such as referral management, which runs across several systems. Qventus also supplies the commercial software HonorHealth uses for patient throughput and operating room utilization.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.